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Abstract: The potential toxic effects of silver nanoparticles (AgNPs), administered by a single
intratracheal instillation (i.t), was assessed in a rat model using commercial physico-chemical
characterized nanosilver. Histopathological changes, overall toxic response and oxidative stress
(kidney and plasma protein carbonylation), paralleled by ultrastructural observations (TEM),
were evaluated to examine renal responses 7 and 28 days after i.t. application of a low AgNP
dose (50 µg/rat), compared to an equivalent dose of ionic silver (7 µg AgNO3/rat). The AgNPs
caused moderate renal histopathological and ultrastructural alteration, in a region-specific manner,
being the cortex the most affected area. Notably, the bulk AgNO3, caused similar adverse effects
with a slightly more marked extent, also triggering apoptotic phenomena. Specifically, 7 days after
exposure to both AgNPs and AgNO3, dilatation of the intercapillary and peripheral Bowman’s
space was observed, together with glomerular shrinkage. At day 28, these effects still persisted
after both treatments, accompanied by an additional injury involving the vascular component of
the mesangium, with interstitial micro-hemorrhages. Neither AgNPs nor AgNO3 induced oxidative
stress effects in kidneys and plasma, at either time point. The AgNP-induced moderate renal effects
indicate that, despite their benefits, novel AgNPs employed in consumer products need exhaustive
investigation to ensure public health safety.
Keywords: nanotoxicity; in vivo; histology; renal ultrastructure
1. Introduction
With the recent advances in nanotechnology, the increasing exploitation of engineered
nanoparticles (NPs) has raised great concern regarding the potential for manufacturer and consumer
exposure. Many of these manufactured nanomaterials are composed of metal and metal oxides,
and several studies have evidenced the presence of metal-containing NPs in different occupational
environments [1–3]. Metal NPs have achieved meaningful attention due to their technological interest,
based on their excellent properties owing to their large surface area to volume ratio. Among these NPs,
AgNPs have demonstrated an application in optical receptors, bio-labeling, and intercalation materials
for electrical batteries. Furthermore the peculiar activities of silver nanoparticles have resulted in their
widespread uses in consumer products and medical devices. Specific details for the current worldwide
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applications of AgNPs are summarized in reviews by McGillicuddy et al. [4] and Mackevica and Foss
Hansen [5].
The risk of exposure to silver nanoparticles is ever increasing for both workers at
nanosilver-manufacturing workplaces and consumers using nanosilver-containing products [6]. It is
well known that NPs exposure, by direct or indirect mechanisms, may lead to unexpected distant
responses, with overt toxic effects also involving distant organs e.g., kidneys [7,8]. The toxicity of
nanosilver is still a highly debated topic in the literature and in the reports of several regulatory bodies.
In fact, although the toxicology of silver and its compounds is well known, there are still gaps in the
risk assessment of silver in the form of AgNPs [9–11].
Although a body of literature has been published on nanosilver, the main uncertain issue to be
clarified regarding the nanosilver safety is to assess the toxic potential of nanosilver compared to that
of its bulk counterpart material, also considering that the size, shape, and surface coatings of such
AgNPs may greatly impact on their toxicity.
Several toxicity studies on AgNPs have been performed on bacteria and non-mammalian animal
species, providing still comparatively limited data [12]. A number of experimental studies, both
in vitro and in vivo, have pointed out toxic properties of nanosilver in a wide range of concentrations
and sizes. Smaller AgNPs have been shown to be more active in exerting toxicological responses,
with faster rates of Ag dissolution and higher cytotoxic potential at sub-acute time-points in vitro [13],
also inducing organ toxicity and inflammatory responses after repeated oral administration in vivo [14].
Other investigations suggest the mild toxicity of AgNPs, which become toxic only when oxidized to
silver ions, Ag+. Numerous in vitro studies have demonstrated the size-, dose- and cell-dependent
cytotoxic and genotoxic effects of AgNPs, including reactive oxygen species (ROS) generation and lipid
peroxidation, with the consequent production of carbonylated proteins (PCOs) [15]. Protein carbonyl
formation is caused by the introduction into proteins of carbonyl derivatives such as aldehydes and
ketones, generated from direct oxidation processes or from secondary protein reaction with reactive
carbonyl compounds, eventually forming advanced glycation end products (AGEs) and advanced
lipoxidation end products (ALEs) [16]. Moreover, aldehydes, as well as ROS, can affect a variety of
biological processes, including transcription factor activation, gene expression, and production of
inflammatory cytokines [17].
Several in vivo studies have been conducted using different routes of exposure, with the effort
to depict AgNPs kinetics, tissue distribution and overall toxicity, also employing diverse animal
species to evaluate different biological responses [12,14,18–20]. AgNP toxicological data coming from
in vivo studies pointed out (i) diverse toxic responses on different target organs and systems, either
after single or repeated administration and different treatment routes [12,21–25]. In particular, several
investigations (see review by Iavicoli et al. [26]) proved that AgNPs are able to induce serious functional
and structural alterations in all kidney regions (i.e., cortex, inner and outer medulla), causing for
example glomerular and Bowman’s space modification, swelling and cytoplasmic vacuolization of
the tubular epithelium, basement membrane thickness, and swollen podocytic secondary processes.
Nevertheless, it should be underlined that these results need to be interpreted with care since high and
unrealistic single exposure doses and non-physiological routes of exposure have been used.
In the current study we adopted an integrated approach including both in vivo toxicology studies
and physicochemical characterization of the AgNPs, to assess the potential toxic effects associated
with the exposure to a commercial nanosilver. Histochemical and molecular endpoints, in terms
of histopathological changes, overall toxic response and oxidative stress (i.e., tissue/organ and
plasma protein carbonylation), paralleled by ultrastructural observations using transmission electron
microscopy (TEM), were carried out to examine renal responses in rats after intratracheal instillation
(i.t.) of a low dose of AgNPs (50 µg/rat).
The effects of AgNPs was assessed at 7 and 28 days post-exposure in comparison with those caused
by administration of an equivalent dose of ionic silver in the form of silver nitrate (7 µg AgNO3/rat,
corresponding to 4.4 µg Ag).
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2. Results
No significant toxicity signs or mortality were observed in the animals after exposure to both
AgNP or AgNO3, neither 7 days post treatment nor during the recovery periods (until 28 days).
The body weight (b.w.) gain of treated rats was comparable to that measured from controls: the b.w.
from day zero to the last day of treatment (day 28) increased by about 40% in all groups.
2.1. Model Silver Nanoparticles (AgNPs): Physicochemical Characteristics
The characteristics of AgNP 1% in water, with the appearance of brown color were 1 g/cm3
density, 3 mPa/s viscosity (25 ◦C), <0.50 PdI, 6.5 pH, and 20 nm nominal hydrodynamic size diameter.
Dynamic light scattering determination (Malvern Instruments Ltd., Malvern, UK) of AgNP size
distribution shows two populations of particles in the ranges of 20 and 100 nm, respectively (Figure 1).
Particle samples were vortexed prior to measurement although no tendency to agglomerate was
detected. For an exhaustive physicochemical characterization, see [27].
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Figure 1. Size distribution determined by dynamic light scattering (DLS) measurements of model 
AgNPs in deionized water. Modified from Coccini et al. [27]. 
2.2. Histopathology: Haematoxylin & Eosin (H & E) Staining 
Light microscopy photomicrographs of H & E-stained tissues showed histopathological changes 
of the renal architecture mainly localized in the cortical area, already observable 7 days after 
exposure, and lasting until day 28, to both AgNP and AgNO3 materials, (Figure 2) with a slightly 
more marked effect caused by AgNO3 (Table 1). 
Seven days after both AgNO3 or AgNPs instillation, the main alterations were the enlargement 
of the Bowman’s capsule paralleled by glomerular shrinkage. Specifically, in some places glomeruli 
appeared deformed, often collapsed or showing packed mesangial and endothelial cells (Figure 2). 
Edematous, hemorrhagic glomeruli were found 28 days after both treatments, displaying the 
alterations of the vascular component of the renal mesangium, with the capillary loops sometimes 
distorted, and evident interstitial micro-hemorrhages (Figure 2). Within the cortical area, the AgNP- 
and AgNO3-dependent effects were mainly depicted at the glomerular level, while no evident 
alterations were observed at tubular level, with AgNO3 inducing a more marked effect. 
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2.2. Histopathology: Haematoxylin & Eosin (H & E) Staining
Light icroscopy photo icrographs of & E-stained tissues sho ed histopathological changes
of the renal architecture mainly localized in the cortical area, already observable 7 days after exposure,
and lasting until day 28, to both AgNP and AgNO3 materials, (Figure 2) with a slightly more marked
effect caused by AgNO3 (Table 1).
Seven days after both AgNO3 or AgNPs instillation, the ain alterations were the enlarge ent
of the Bow an’s capsule paralleled by glo erular shrinkage. Specifically, in so e places glo eruli
appeared defor ed, often collapsed or sho ing packed esangial and endothelial cells (Figure 2).
Ede atous, hemorrhagic glomeruli were found 28 days after both treatments, displaying the alterations
of the vascular component of the renal mesangium, with the capillary loops sometimes distorted,
and evident interstitial micro-he orrhages (Figure 2). Within the cortical area, the AgNP- and
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AgNO3-dependent effects were mainly depicted at the glomerular level, while no evident alterations
were observed at tubular level, with AgNO3 inducing a more marked effect.Int. J. Mol. Sci. 2017, 18, 2115  4 of 15 
 
 
Figure 2. Representative H&E-stained cortical renal specimens from control animals (a,g) and rats 
exposed to AgNPs (b,c,h) or AgNO3 (d–f,i), 7 and 28 days post-instillation. The physiological renal 
structure is clearly well preserved in control rats (a,g), while moderate morphological alterations are 
manifest in the renal cortex of the treated animals, at both evaluated time points. Seven days post-i.t., 
the dilatation of the intercapillary and peripheral Bowman’s space was observed (b,d,e), often 
accompanied by glomerular shrinkage (d); these effects were still evident after both treatments at day 
28 (c,h for AgNPs and f, i for AgNO3) accompanied by the appearance of several glomerular areas of 
interstitial micro-hemorrhages. Objective magnification: 40× (a–d,f); 20× (e), 10× (g–i). 
Table 1. Semi-quantitative scoring of renal lesions in control and treated rats. 
7 Days  p Value
 Control AgNPs AgNO3  
Bowman’s capsule enlargement − ++ +++ * 
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Edema and interstitial micro-hemorrhages − ++ +++ * 
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Degree scale: from absent (−) to severe (+++). p values calculated by Kruskal–Wallis test: (*) <0.05; ns = 
not statistically significant. 
  
Figure 2. Representative H&E-stained cortical re al specimens from control animals (a,g) and rats
exposed to AgNPs (b,c,h) or AgNO3 (d–f,i), 7 an s ost-instillation. The physiological renal
structure is clearly well preserved i ntrol rats (a,g), while moderate morphologic l alterations
are manifest i the renal cortex of the treated animals, at both evaluated time points. Seven days
post-i.t., the dilatation of the intercapillary and peripheral Bowman’s space was observed (b,d,e),
often accompanied by glomerular shrinkage (d); these effects were still evident after both treatments at
day 28 (c,h for AgNPs and f, i for AgNO3) accompanied by the appearance of several glomerular areas
of interstitial micro-hemorrhages. Objective magnification: 40× (a–d,f); 20× (e), 10× (g–i).
Table 1. Semi-quantitative scoring of renal lesions in control and treated rats.
7 Days p Value
Control AgNPs AgNO3
Bowman’s capsule enlargement − ++ +++ *
Mesangial cells and glomerular capillaries shrinkage − ++ ++ *
Edema and interstitial micro-hemorrhages − ++ +++ *
Podocyte foot pr cesses alteration − + + ns
Apoptosis − − ++ *
28 Days p Value
Control AgNPs AgNO3
Bowman’s capsule enlargement − ++ +++ *
Mesangial cells and glomerular capillaries shrinkage − ++ ++ *
Edema and interstitial micro-hemorrhages − ++ +++ *
Podocyte foot processes alteration − + + ns
Apoptosis − − ++ *
Degree scale: from absent (−) to severe (+++). p values calculated by Kruskal–Wallis test: (*) <0.05; ns = not
statistically significant.
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2.3. Transmission Electron Microscopy (TEM) Observations: UA & LC Staining
The renal cortical tissues of the control rats revealed a normal physiological appearance of
the kidney’s (i.e., corpuscles and tubules) ultrastructural patterns (Figure 3a). In contrast, in
accordance with histopathological evidence, ultrastructural changes as a consequence of AgNP
and AgNO3-exposure were demonstrated (Figure 3b–f and Table 1). Specifically, after AgNP
exposure, the renal corpuscles displayed extensive congestion, filling up the glomerular capillary
loops. Some glomeruli were shrunk with concurrent dilatation of the intercapillary and peripheral
Bowman’s space (Figure 3d); nevertheless, the glomerular basement membrane displayed a normal
physiological thickness. Shrinkage of both mesangial cells and glomerular capillaries was also observed,
accompanied by the presence of scarcely-developed podocyte foot processes (Figure 3e). The same
changes were observed in the cortical area of AgNO3-exposed rats, where cell death was also revealed
(Figure 3b,c). Specifically, no presence of necrosis was detected, nonetheless paralleled by the presence
of several apoptotic cells; damaged endothelial and podocyte cells, ultra-structurally characterized by
nuclear pyknosis, karyorrhexis, cytoplasmic segmentation and apoptotic body formation, were found
after AgNO3 treatment (Figure 3b,c), already at the early time point (day 7) and persisting until day 28.
Int. J. Mol. Sci. 2017, 18, 2115  5 of 15 
 
2.3. Transmission Electron Microscopy (TEM) Observations: UA & LC Staining 
The renal cortical tissues of the control rats revealed a normal physiological appearance of the 
kidney’s (i.e., corpuscles and tubules) ultrastructural patterns (Figure 3a). In contrast, in accordance 
with histopathological evidence, ultrastructural changes as a consequence of AgNP and AgNO3-
exposure were demonstrated (Figure 3b–f and Table 1). Specifically, after AgNP exposure, the renal 
corpuscles displayed extensive congestion, filling up the glomerular capillary loops. Some glomeruli 
were shrunk with concurrent dilatation of the intercapillary and peripheral Bowman’s space (Figure 
3d); neverthel ss, the glomerular basement membrane displ y d a normal physiologic l thick ess. 
Shrinkage of both mesang al cells and glomerular capil aries was also observed, accompanied by the 
presence of scarcely-d v loped podo yte foot pr cesses (Figure 3e). The same changes wer  observed 
i  the cortical ar a of AgNO3-exposed rats, where cell d ath was also reveal d (Figure 3b,c). Specifically, 
no presence of necrosis was detected, no etheless paralleled by the presence of several apoptotic cells; 
damaged endothelial and podocyte cells, ultra-structurally characterized by nuclear pyknosis, 
karyorrhexis, cytoplasmic segmentation and apoptotic body formation, were found after AgNO3 
treatment (Figure 3b,c), already at the early time point (day 7) and persisting until day 28. 
 
Figure 3. Transmission electron microscopy images (UA & LC staining) showing moderate renal 
cortical alteration 7 and 28 days after AgNP- and AgNO3-instillation. The evident dilatation (asterisks) 
of the intercapillary and peripheral Bowman’s space (d,f) is shown together with shrinkage of both 
mesangial cells and glomerular capillaries; endothelial and podocytic cells appeared damaged (b,c, 
asterisks), the latter showing the podocyte foot processes scarcely developed (e). Occasional 
expression of cell injury, namely apoptotic cell death and cytoplasm segmentation are also presented 
(b,c). Original magnification: ×4400 (a–c); ×3000 (d–f). 
Figure 3. Transmission electron microscopy images (UA & LC staining) showing moderate renal cortical
alteration 7 and 28 days after AgNP- and AgNO3-instillation. The evident dilatation (asterisks) of the
intercapillary and peripheral Bowm n’s space (d,f) is shown together with shrinkage of both mesangial
cells and glomerular capillaries; endothelial and podocytic cells appeared damaged (b,c, asterisks),
the latter howing he podocyte foot rocesses scarcely dev loped (e). Occasional expression of cell
injury, namely apoptotic cell death and cytoplasm segmentation ar also present d (b,c). Original
magnificatio : ×4400 (a–c); ×3000 (d–f).
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2.4. Oxidative Stress Evaluation by Protein Carbonylation Assessment in Kidney Slice Homogenates and Plasma
PCOs are widely analyzed as a measure of severe protein oxidation and employed as a biomarker
of oxidative stress. One of the most commonly used method for determining PCOs relies on the
derivatization of the carbonyl group with 2,4-dinitrophenylhydrazine (DNPH), which generates
the stable 2,4-dinitrophenylhydrazone (DNP)-carbonyl adduct. Derivatized PCOs can be detected
quantitatively by immunoassay using high specificity antibodies against DNP. The results of protein
carbonylation assessed by Western blotting using anti-DNP antibodies from rats treated with AgNPs
or AgNO3 are shown in Figure 4. At both considered time points (i.e., 7 and 28 days after a single
i.t. instillation), treatment with AgNPs or AgNO3 did not induce any increase in protein carbonyls
compared with controls, in both kidney homogenates and plasma proteins. No immunostaining was
observed in parallel experiments in which either the protein samples were treated with NaBH4 or the
primary antibody to DNP was omitted.
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Western blot with anti-DNP antibody for PCOs of kidney slice homogenates (A) and plasma proteins
(B) of l Sprague–Dawley rats treated with a single i.t. instillation of AgNPs or AgNO3.
In both (A) and (B): 1, control (7 days); 2, AgNO3 (7 days); 3, AgNPs (7 days); 4, control 28 days);
5, AgNO3 (28 days); 6, AgNPs (28 days). (C) human serum albumin (HSA) in the reduced form (−)
and in the carbonylated/oxidized f rm (+). Protein molecular weight markers are shown on the left
side of eac panel. Although there w re no differ ces between controls and tr ated samples, the most
ca bonylated proteins are highlighted by a asterisk (*) in kidney and plasma samples.
3. Discussion
In the latest decades, growing worldwide attention has been devoted to engi eer d NPs ba ed on
their putative novel applications in a variety of consumer and occupational fields.
However, not enough studies have ruled out the potential hazards due to NPs and hence the
definitive conclusions and tools, technologies, syste s, and ethods to obviate the risks are still
elusive. l tools for the assessment of the ri ks are still at the conceptu l st ge, and furt ,
there are considerable uncertainties as t how to measure NP exposure (i.e., ich t i t adopt
systematically) and to as es their toxicity [28].
Thus, being unable to perfor a quantitative risk as ess ent for NPs, it should be made
mandatory to prevent exposure by appropriate precautionary measures and practicing best industrial
hygiene to avoid f t re s i f i t l tio al exposures [29,30].
In the safety as es ment area, it is crucial to define adequate strategies and establish whether NP
tailored testing methods should be added to conventional toxicity testing protocols to comply with
regulatory demand and properly characterize NP potential hazards.
Ac ording to the major institutions and inter ational consensus meetings, a proposed multi-tiered
testing protocol is re mmended to a dress toxicological research and health risk ssessment for NPs.
The toxicity strategy should firstly include an exhaustive phy icochemical chara teriz tion, the use
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of validated cellular (in vitro) models, followed by limited and focused in vivo studies. Specifically,
investigations in laboratory animals may provide essential insight, providing pivotal data, contributing
to clarifying the NP toxicity mechanisms, also allowing us to understand toxicity targets at different
molecular levels, to improve the overall knowledge of the adverse outcomes that may result from NP
exposure [29–31].
The present in vivo investigation addressed the renal effects of AgNPs compared to a bulk
counterpart material i.e., AgNO3, investigating histochemical and molecular endpoints, 7 and 28 days
after a single i.t. instillation.
Our data demonstrated that a single AgNP i.t. low dose administration caused moderate renal
damage, in term of histopathological and ultrastructural alteration, in a region-specific manner, with
the cortex the most affected area, without generation of PCOs. Notably, the employed counterpart
silver nitrate (AgNO3) caused similar adverse effects with a slightly more marked extent, specifically
also triggering apoptotic phenomena.
Specifically, (i) 7 days after exposure to both AgNPs and AgNO3, the main renal changes concerned
the Bowman’s capsule (in terms of dilatation of the intercapillary and peripheral Bowman’s space) as
well as the glomerular shrinkage; (ii) after 28 days these effects still persisted after both treatments,
accompanied by a further injury involving the vascular component of the renal mesangium, with
evident interstitial micro-hemorrhages. These overall changes were slightly more marked after AgNO3
exposure compared to AgNP, with apoptotic phenomena observed in AgNO3-treated animals only.
The evaluation of PCOs in both kidney (organ response to oxidative stress) and plasma (systemic
response to oxidative stress) samples indicated that a single exposure to AgNPs or AgNO3 was devoid
of any oxidative stress effects, at both the considered time points (i.e., 7 and 28 days after treatment),
as demonstrated by PCO occurrence similar to that observed in control rats.
A bulk of experimental investigations indicate that, despite the indubitable AgNP benefits,
they may pose a serious hazard to various organisms [21,32–36]. Hence, there is a need for
research on low-level toxicity of nanosilver, which may mimic the occupational, environmental
and consumer exposure scenario [37,38]. To this aim, the present study tested a dose of 50 µg
AgNPs/rat, corresponding to a dose of about 200 µg/kg b.w., based on a previous investigation by
Takenaka et al. [37], reporting lung toxicity as well as NP translocation to the systemic circulation with
consequent deposition in distant organs, e.g., kidney, after a single i.t. exposure to AgNPs with 15 nm
modal diameter. A parallel study by the same authors, using inhalation as the route of treatment,
employing the identical NP type (AgNPs of about 15 nm), at a correspondent dose of 133 µg/m3
AgNPs (for 6 h exposure), showed that the highest concentrations of silver were found in the lungs
and blood, whereas low concentrations were measured in the liver, kidneys, spleen, brain and heart, as
a consequence of translocation, i.e., the ability to reach secondary organs via the bloodstream [37].
Another recent work by Silva et al. [38] tested a range of low AgNP doses (i.e., from 30 to
300 µg/rat) with different nominal diameters (i.e., 20 and 110 nm) using a single i.t. exposure.
The authors established that these selected doses would approximate human occupational and
consumer exposure in a worst-case scenario. All AgNP types produced significant inflammation
throughout the experimental time course (1–21 days), after 150 and/or 300 µg/rat doses. Pulmonary
histology alterations were also detected in animals exposed to 300 µg/rat AgNPs only.
Moreover, it has to be mentioned that Takenaka and colleagues [37] demonstrated by inductively
coupled plasma mass spectrometry (ICP-MS) analysis that only 9–16 µg of the 50 µg AgNP instilled
was retained in the lung on day one after the i.t. exposure, remaining almost unchanged until
day 7. In contrast, rapid clearance of instilled water-soluble AgNO3 from the lung was observed.
When AgNPs were tested by inhalation, Ag content was also determined in different organ tissues.
In particular, Ag content in the kidney was 45 ± 10 ng one day after exposure, decreasing to
approximately 5 ± 5 ng at day four.
In line with these data, another recent investigation [39] testing AgNPs at a total dose of
100 µg/mouse administered by oropharyngeal aspiration (20 µg single dose/aspiration, once a week
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for five weeks), demonstrated pronounced pulmonary toxic effects paralleled by NP translocation to
secondary organs, determined two and 28 days after final treatment. Specifically, renal Ag content,
measured by ICP-MS, was about 0.01 ng/mg tissue at the first evaluated timepoint, decreasing about
three- to four-fold at the latest detection.
In a recent study by Arai et al. [40], 20 nm AgNP suspension and AgNO3 solution were i.t.
instilled at a dose of 10 µg Ag/mouse. Pulmonary toxicity in terms of bronchoalveolar lavage (BALF)
alterations (e.g., an increase of proinflammatory cytokines and neutrophils), as well as translocation
to distant organs, were demonstrated after exposure to both compounds. The concentration of Ag
in the lung tissue of AgNP-treated mice was significantly higher than that in AgNO3-treated mice
at four and 24 h after instillation. Furthermore, in AgNP-treated mice, only a trace amount of Ag
was detected in the liver, while, in contrast, 7% of the initial dose of Ag was recovered in the liver of
AgNO3-treated mice 4 h after treatment, suggesting that the ionic form of silver was absorbed by the
lung tissue and entered the systemic circulation more efficiently than AgNPs. In fact, the renal Ag
concentration in AgNO3-instilled mice was 0.046 ± 0.033 µg/g tissue, corresponding to about 2% of
the initial Ag instilled dose. Differently, in AgNP-treated animals, the Ag concentration in the kidney
was undetectable, being below Limit of detection (LOD) at both considered timepoints, i.e., 4 and 24 h
after i.t. administration.
In line with the above literature, in the present study a low dose of AgNPs was tested compared
to an equivalent dose of ionic silver in the form of AgNO3. The chosen dose (50 µg/rat corresponding
to 200 µg/kg b.w.) and the AgNP type were used to mimic occupational and consumer exposure to
engineered NPs (ENPs) used in paints and coatings, in that, among the industrial applications, coatings,
paints, and pigments are the most important applications of ENPs in terms of overall use [39,41].
Occupational exposure to AgNPs used in paints and coatings can occur during the production
process, handling and application. Activities such as scratching (by children, pets), cleaning, UV
exposure, and demolition can damage the coatings resulting in the release of NPs into the environment.
Respiratory inhalation is the most probable route of exposure to environmental dust [42]. Several
investigations have further demonstrated that NPs entering the body through the pulmonary system
or another portal of entry reached the blood circulation and were then transported to various distant
target organs [43–47].
According to the well-known NP translocation ability, our results contribute to pointing out the
modest involvement of a secondary organ (i.e., the kidney, a known target organ for silver toxicity) in
the action of AgNPs introduced by pulmonary instillation. The moderate renal response may be due
to the migration of the nanoparticles from the lung to the systemic circulation or to secondary organ
changes caused by circulating inflammatory factors released from the lung following local insult [48].
A direct renal action of silver ions released from the absorbed AgNPs can also not be excluded [47],
although good stability of the silver NPs should be postulated based on a recent study using an in
silico PBPK (physiologically based pharmacokinetic) model by Bachler and colleagues [49], which
demonstrated that AgNPs administered in vivo are directly stored as insoluble salt particles rather
than dissolved into Ag+.
In the current investigation, the kinetics of Ag distribution was not investigated based on previous
experimental works, employing similar doses and demonstrating renal Ag content below the detection
limit 24 h after exposure [40].
According to previous data, revealing AgNP accumulation in the kidney cortical and medullar
regions, mainly deposited in the top of the cortical glomeruli within the cytoplasm of mesangial
cells [19,50–52], our current investigation evidenced moderate renal alterations, in terms of the
enlargement of the Bowman’s capsule paralleled by glomerular shrinkage 7 days after AgNP i.t.
low dose administration, with a persistence of these effects at day 28, with a further injury involving
the vascular component of the renal mesangium. Morphological and ultrastructural renal modification
could be paralleled by functional consequences, such as tubular dysfunction or glomerular filtration
damage. In this view, the use of some functional parameters could allow the detection of AgNP-induced
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early renal dysfunction. In particular, as previously demonstrated by Fontana and colleagues [53]
using metal NPs, potential peripheral markers of renal NP-induced effects, such as urinary retinol
binding protein and β2-microglobulin, could be extremely useful for risk assessment and management
in occupational and environmental exposure scenarios.
In conclusion, our data demonstrated that even following a single i.t. instillation of a low
dose, AgNPs may moderately affect renal tissue, indicating that, despite the incontestable benefits,
novel AgNPs employed in a huge number of consumer products may pose a threat to public health.
This concern implies a careful investigation approach consisting of detailed toxicological studies
paralleled by a comprehensive physico-chemical characterization.
4. Materials and Methods
4.1. Chemicals
The AgNPs were kindly provided by Colorobbia (Colorobbia S.p.A., Vinci, Italy), series
PARNASOS NAMA 39 1103 F01 1%, for details see Section 2.1. Haematoxylin and Eosin
alcoholic solution staining were purchased from Ettore Pasquali S.r.L. (Milan, Italy). The
2,4-dinitrophenylhydrazine (DNPH) was purchased from Sigma-Aldrich (Sigma-Aldrich, Milan,
Italy). Anti-dinitrophenyl-KLH (anti-DNP) antibodies, rabbit IgG fraction and goat anti-rabbit IgG,
horseradish peroxidase conjugate, were purchased from Molecular Probes (Eugene, OR, USA). ECL
Plus Western blotting detection reagents were obtained from GE Healthcare (Milan, Italy). All reagents
of analytical grade were kindly provided by the Eureka Lab Division (Chiaravalle, AN, Italy). All other
reagents were purchased from Sigma-Aldrich (Milan, Italy).
4.2. Animals and Experimental Design of Silver Exposure
Adult male Sprague–Dawley rats (12 weeks old), purchased from Charles River Italia (Calco, Italy),
were allowed to acclimatize for at least two weeks before treatment, and kept in an artificial 12 h
light:12 h dark cycle with humidity at 50 ± 10% throughout the experiment. Animals were provided
rat chow (VRF1 Mucedola diet) and tap water ad libitum.
The weight of the rats in all treatment groups at time point zero (day of instillation) was 253 ± 9 g.
Groups (n = 6 total for each treatment group at each time point) of rats were treated with a single
intratracheal (i.t.) instillation of AgNPs (50 µg/rat). Separate groups of animals received an equivalent
i.t. dose of ionic silver in the form of AgNO3 (7 µg/rat, corresponding to 4.4 µg Ag) or 0.1 mL
saline/rat (as control). Appropriate doses, durations and routes of exposure were chosen accordingly
to a previous study by Takenaka et al. [37], showing that a single i.t. dose of 50 µg AgNPs/rat induced
lung toxicity and NP translocation to the target organ i.e., kidney. Although intratracheal instillation
(i.t.) is a more artificial route of dosing bolus material to the lungs and there are differences in the
distribution, behavior, clearance and retention of materials when administered by i.t. compared
to inhalation, the former is widely used to address specific endpoints regarding the toxicity of
nanomaterials [37,40,54–58].
The AgNP suspension was vortexed on ice just before exposure to force nanoparticle dispersion
and avoid the formation of agglomerates. No surfactants or solvents were used. 7 and 28 days
after treatment, the rats were euthanized with an overdose i.p. injection of 35% chloral hydrate
(100 mL/100 g body weight (b.w.)). Blood was withdrawn and centrifuged to obtain plasma, and
the kidneys were excised. All samples were processed for (i) histopathology (i.e., H & E staining),
(ii) ultrastructural evaluation by transmission electron microscopy (TEM) and (iii) oxidative stress
evaluation by protein carbonylation determination. Specifically, protein carbonylation is a major form
of protein oxidation and is widely used as an indicator of oxidative stress [59–61].
The study was conducted within the CARIPLO Project—Rif. 2011–2096, under Italian Legislation
of research protocol, in compliance with the European Council Directive 2010/63/EU on the care and
use of laboratory animals. A research protocol entitled “Molecular and cellular studies on metal-doped
Int. J. Mol. Sci. 2017, 18, 2115 10 of 15
nanoparticles. A research strategy aimed at characterizing the biological risk”, was submitted (delivery
notice n. 13898498944-4, 1 April 2010) to the Italian Ministry of Health which formally approved it
with a tacit consent. All animals used in this research were treated humanely according to institutional
guidelines, with due consideration for the alleviation of distress and discomfort. Rats were anesthetized
with pentobarbital sodium before i.t. instillation with the test materials.
4.3. Kidney Histology and Ultrastructural Morphology Evaluations
For each treatment at each time point, renal tissues were processed for the following
morphological evaluations.
4.3.1. Rat Renal Specimen Preparation and Histology
At necropsy, the kidneys from control and treated animals were carefully removed and
hemi-dissected. One half of each kidney was washed in NaCl 0.9% and post-fixed by immersion for
7 h in 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4), dehydrated through a graded series
of ethanol and finally embedded in Paraplast. Seven micrometer-thick sections of the samples were cut
in the coronal plane and collected on silane-coated slides. Subsequently, to evaluate overall structural
changes by light microscopy, H & E staining was performed. The slides were then observed and
scored with a bright-field Zeiss Axioscop Plus microscope (Carl Zeiss S.p.A., Milan, Italy). Specifically,
five slides (20 sections) per animal (n = 6) were analyzed; five microscopic fields were examined in
each section for each rat per time/condition.
The images were recorded with an Olympus Camedia C-5050 digital camera and stored on a PC
running Olympus software (Olympus Italia S.r.l., Segrate, Italy).
4.3.2. Transmission Electron Microscopy (TEM): UA & LC Staining
Kidney fragments (small blocks of about 1 mm3) were fixed for 4 h by immersion in ice-cold
1.5% glutaraldehyde (Polysciences, Inc., Warrington, PA, USA) buffered with 0.07 M cacodylate buffer
(pH 7.4), containing 7% sucrose, followed by post-fixation in OsO4 (Sigma Chemical Co., St. Louis, MO,
USA) in 0.1 M cacodylate buffer (pH 7.4) for 2 h at 4 ◦C, dehydrated in a graded series of ethanol and
embedded in Epon 812. For light microscopy pre-examination, semithin sections (1 micrometre thick)
were stained with 1% borated methylene blue. For electron microscopy, ultrathin sections (about 600 Å
thick) were cut from the blocks, mounted on uncoated 200-mesh-copper grids, and doubly stained
with saturated uranyl acetate in 50% acetone and Reynold’s lead citrate solution. The specimens were
examined with a Zeiss EM 300 electron microscope (Carl Zeiss S.p.A) operating at 80 kV.
4.3.3. Semiquantitative Kidney Lesion Analysis
A scoring system was used to evaluate the extent of renal damage using conventional brightfield
microscopy according to a semiquantitative scale ranging from undetectable (−) to severe (+++).
Specifically, 20 sections per n = 3 animals were analyzed, examining five microscopic fields in each
section for each rat per time/condition.
The localization and degree of lesions was recorded and graded as follows: (−) absent/
undetectable lesions; (+) mild injury; (++) moderate damage; (+++) severe alteration. Specifically, the
following alterations were recorded: Bowman’s capsule enlargement, mesangial cells and glomerular
capillaries shrinkage, edema and interstitial micro-hemorrhages, podocytic foot process alteration,
apoptotic phenomena.
4.3.4. Statistical Analysis
Differential renal lesion extent data were not normally distributed; therefore, the Kruskal–Wallis
nonparametric test was used. Statistical significance is indicated with a * (p value < 0.05).
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4.4. Oxidative Stress Evaluation: Detection of Protein Carbonylation in Kidneys and Plasma
Control, AgNO3 and NP-treated (7 and 28 days) kidney slices were homogenized with potter
(40 cycles) in ice-cold lysis buffer (50 mM Tris–HCl, pH 7.4, 150 mM NaCl, 5 mM EDTA, 1% Triton
X-100 supplemented with proteases inhibitors (P8340 SIGMA)). Lysates were incubated on ice for
30 min and centrifuged at 14,000× g for 15 min at 4 ◦C to remove tissue debris. Clarified supernatants
were quantified for protein content using BCA assay and stored at −80 ◦C until protein carbonylation
immunoassay. Plasma from control, AgNO3 and NPs-treated (7 and 28 days) mice were diluted 1:40 in
50 mM PBS pH 7.4, quantified for protein content using Bradford assay and stored at −80 ◦C until
protein carbonylation immunoassay.
Kidney (10 µg) and plasma proteins (5 µg) were fractionated on 12% (w/v) reducing SDS-PAGE
gels and electroblotted onto a polyvinylidene difluoride (PVDF) membrane. Protein carbonylation was
detected, after derivatization with DNPH, with anti-DNP antibodies specific for the 2,4-dinitrophenyl
hydrazone–protein adduct by Western blot immunoassay [59–61]. In particular, PVDF membranes
were subsequently incubated in 2 M HCl and DNPH (0.1 mg/mL in 2 M HCl) for 5 min each.
Membranes were then washed three times in 2 M HCl and seven times in 100% methanol for 5 min
each, followed by one wash in PBST (10 mM Naphosphate, pH 7.2, 0.9% (w/v) NaCl, 0.1% (vol/vol)
Tween-20) and blocking for 1 h in 5% (w/v) nonfat dry milk in PBST. After washing three times with
PBST for 5 min each, carbonyl formation was probed by 2-h incubation with 5% milk/PBST containing
anti-dinitrophenyl-KLH (anti-DNP) antibodies (1:10,000 dilution). After three washes with PBST for
5 min each, the membrane was incubated with a 1:40,000 dilution of the secondary antibody linked to
horseradish peroxidase in 5% milk/PBST for 1 h. After washing three times with PBST for 5 min each,
immunostained protein bands were visualized with enhanced chemiluminescence detection. Protein
bands on PVDF membranes were then visualized by washing the blots extensively in PBS and then
staining with amido black.
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